Follow-up report on the 2-year cardiac data from a deferasirox monotherapy trial

American Journal of Hematology

Volumn 85, Issue 10, 2010, Pages 818-819

  Wood, John C ^a   Glynos, Tara ^b   Thompson, Alexis ^c   Giardina, Patricia ^d   Harmatz, Paul ^e   Kang, Barinder P ^b   Paley, Carole ^b   Coates, Thomas D ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c CHILDREN'S MEMORIAL HOSPITAL   (United States)

^d WEILL CORNELL MEDICAL CENTER   (United States)

^e CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFERASIROX; FERRITIN; IRON; BENZOIC ACID DERIVATIVE; IRON CHELATING AGENT; TRIAZOLE DERIVATIVE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; FOLLOW UP; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LIVER HEMOSIDEROSIS; MONOTHERAPY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; BETA THALASSEMIA; BLOOD TRANSFUSION; CARDIOMYOPATHIES; CHELATION THERAPY; COMPLICATION; HEART STROKE VOLUME; LIVER DISEASES; SIDEROSIS; TREATMENT OUTCOME;

BENZOATES; BETA-THALASSEMIA; BLOOD TRANSFUSION; CARDIOMYOPATHIES; CHELATION THERAPY; FERRITINS; FOLLOW-UP STUDIES; HUMANS; IRON CHELATING AGENTS; LIVER DISEASES; SIDEROSIS; STROKE VOLUME; TREATMENT OUTCOME; TRIAZOLES;

EID: 77957674350     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21830     Document Type: Article

References (1)

1. Wood JC, Kang BP, Thompson A, et al. The effect of deferasirox on cardiac iron in thalassemia major: Impact of total body iron stores. Blood 2010;116:537-543.